Leading Independent Advisory Firm ISS Recommends Columbia Care Shareholders Vote FOR the Transaction with Cresco Labs
CANNANNEW REPORT

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., today announced that leading independent firm Institutional Shareholder Services (“ISS”) has recommended that shareholders vote “FOR” the previously announced transaction with Cresco Labs (“Cresco”) at the Company’s upcoming Special Meeting of Shareholders (the “Special Meeting”) scheduled for July 8, 2022. “We are pleased that ISS supports our Board’s unanimous recommendation that shareholders vote ‘FOR’ the transaction with Cresco,” said Nicholas Vita, Co-Founder, CEO of Columbia Care. “We look forward to our shareholder vote and delivering on the value of this combination for all stakeholders. We’re grateful to our employees and team members who have remained focused on serving our patients and customers, working diligently to execute on our strategic priorities.” Columbia Care Special Meeting of Shareholders The Special Meeting is scheduled for July 8, 2022 at 10:00 AM EST. All shareholders as of record date May 10, 2022 are entitled to vote at the Special Meeting. The proposed Arrangement Agreement has been unanimously approved by Columbia Care’s Board of Directors and by a special committee of independent directors of Columbia Care, which was appointed by the Columbia Care Board of Directors. The Columbia Care Board of Directors unanimously recommends that shareholders vote FOR the Arrangement. Columbia Care shareholders that have any questions or need assistance in voting their shares should contact the Company’s proxy solicitation agent, Morrow Sodali, at 1-888-999-2785 toll free in North America, or call collect outside North America at 1-289-695-3075 or by email at assistance@morrowsodali.com. Investors are strongly encouraged to read the proxy materials that were filed with the United States Securities and Exchange Commission (the “SEC”) and on SEDAR before authorizing…

Excerpt only …
READ MORE BELOW
Source : Leading Independent Advisory Firm ISS Recommends Columbia Care Shareholders Vote FOR the Transaction with Cresco Labs

reposted by Cannabis News World